SpecTRA; A Study of the Validation of Protein Biomarkers in Transient Ischemic Attack

CompletedOBSERVATIONAL
Enrollment

1,150

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
TIA
Interventions
OTHER

Non-Interventional Study

This is a non-interventional study. However, several blood samples will be taken which would not be taken as part of standard of care.

Trial Locations (2)

T2N 2T9

Foothills Medical Centre, Calgary

V8R 1J8

Vancouver Island Health Authority, Victoria

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genome Canada

OTHER

collaborator

Genome British Columbia

INDUSTRY

collaborator

Genome Alberta

OTHER

collaborator

Vancouver Island Health Authority

OTHER

collaborator

LifeLabs

UNKNOWN

collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Stroke Services BC

UNKNOWN

collaborator

Bruker Daltonics

INDUSTRY

collaborator

British Columbia Centre for Disease Control

OTHER_GOV

lead

Andrew Penn

OTHER

NCT03070067 - SpecTRA; A Study of the Validation of Protein Biomarkers in Transient Ischemic Attack | Biotech Hunter | Biotech Hunter